MESOBLAST

Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes, and kidney disease, orthopedic spine conditions, and cardiovascular disorders.

#SimilarOrganizations #People #Financial #Event #Website #More

MESOBLAST

Social Links:

Twitter

Industry:

Biotechnology Health Care Health Diagnostics

Founded:

2004-01-01

Address:

Melbourne, Victoria, Australia

Country:

Australia

Website Url:

http://www.mesoblast.com

Total Employee:

51+

Status:

Active

Contact:

(212) 880-2060

Email Addresses:

[email protected]

Total Funding:

412.3 M USD

Technology used in webpage:

SPF Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Cloudflare Hosting IIS Cloudflare DNS

Similar Organizations

lucira-health-logo

Lucira Health

Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

human-longevity-logo

Human Longevity

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

radius-health-logo

Radius Health

Radius Health develops drug therapies for osteoporosis and women’s health.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Current Employees Featured

silviu-itescu_image

Silviu Itescu
Silviu Itescu Chief Executive Officer and Managing Director @ Mesoblast
Chief Executive Officer and Managing Director

not_available_image

Paul Rennie
Paul Rennie COO @ Mesoblast
COO

john-mcmannis_image

John Mcmannis
John Mcmannis Executive Vice President, Manufacturing @ Mesoblast
Executive Vice President, Manufacturing

not_available_image

Suzanne Lipe
Suzanne Lipe Vice President, Operations @ Mesoblast
Vice President, Operations

fred-grossman_image

Fred Grossman
Fred Grossman Chief Medical Officer @ Mesoblast
Chief Medical Officer
2019-08-01

eric-a-rose_image

Eric A. Rose
Eric A. Rose Chief Medical Officer (CMO) @ Mesoblast
Chief Medical Officer (CMO)
2022-01-01

william-burns_image

William Burns
William Burns Non-Executive Director @ Mesoblast
Non-Executive Director
2014-03-06

not_available_image

Doreen Morgan
Doreen Morgan VP Global Regulatory @ Mesoblast
VP Global Regulatory
2020-01-01

dan-devine_image

Dan Devine
Dan Devine Consultant @ Mesoblast
Consultant
2012-09-01

Founder

not_available_image

Michael Schuster

silviu-itescu_image

Silviu Itescu

Stock Details

Company's stock symbol is ASX:MSB

Acquisitions List

Date	Company	Article	Price
2010-05-12	Angioblast Systems	Angioblast Systems acquired by Mesoblast	N/A

Investors List

herculescapital_image

Investments List

Date	Company	Article	Money raised
2014-04-09	Osiris Therapeutics	Mesoblast investment in Post-IPO Equity - Osiris Therapeutics	15 M USD

Key Employee Changes

Date	New article
2022-02-01	Mesoblast Appoints Dr. Eric Rose as Chief Medical Officer

Official Site Inspections

http://www.mesoblast.com Semrush global rank: 3.77 M Semrush visits lastest month: 3.58 K

Host Informations
Whois Informations

Loading ...